Foghorn Therapeutics Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| FHTX | BDTX | BBOT | NBP | VYGR | KROS | |
|---|---|---|---|---|---|---|
| Market cap | 124.71M | 108.87M | 184.40M | 117.16M | 115.23M | 214.73M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -2.0 | -1.7 | -0.8 | -0.8 | -1.5 | -1.6 |
| Price/book | -1.5 | 1.1 | 0.6 | 0.6 | 0.7 | 0.8 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −46.75% | −53.23% | −81.29% | −76.29% | −57.14% | −30.80% |
| Today | −1.41% | +4.97% | −0.86% | 0.00% | +2.19% | 0.00% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All FHTX news ›INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Foghorn Therapeutics Inc. - FHTX
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Foghorn Therapeutics Inc. - FHTX | FinancialContent FinancialContent INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Foghorn Therapeutics…
Foghorn Therapeutics (FHTX) Projected to Release Quarterly Earnings on Wednesday
Posted by Sarita Garza on Oct 28th, 2026 Shares of NASDAQ:FHTX opened at $2.05 on Wednesday. Foghorn Therapeutics has a fifty-two week low of $1.79 and a fifty-two week high of $7.61. The business has a 50-day moving average of $3.89 and a…
Andreessen Horowitz lays off most of its portfolio recruiting team
Most members of the firm’s portfolio recruiting team have been laid off; those remaining will move to specialized investment groups. Andreessen Horowitz has laid off most of a 34-person team that helps its portfolio companies recruit…
Foghorn Therapeutics faces securities fraud probe after halting key drug programs and cutting 40% workforce.
Foghorn Therapeutics announced it will not advance its FHD-909 and SMARCA2 degrader programs, ending collaboration with Lilly and cutting its workforce by 40%. Following this, its stock dropped over 30%. Pomerantz LLP is investigating…
FHTX Investors with $100,000 in Losses Have Opportunity to Join Foghorn Therapeutics Inc. Fraud Investigation with SBS Law
FHTX Investors with $100,000 in Losses Have Opportunity to Join F The National Law Review FHTX Investors with $100,000 in Losses Have Opportunity to Join Foghorn Therapeutics Inc. Fraud Investigation with SBS Law LOS ANGELES--(BUSINESS…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- financialcontent.com1
- mezha.net1
- natlawreview.com1
- pluang.com1
- prnewswire.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.